Recall Z-1400-2017— Remel Inc

Class II · Terminated

Class II FDA medical device recall by Remel Inc, initiated 2017-02-09, terminated 2019-05-01. FDA's recall record names no specific 510(k) clearance for this event. Product: Remel, Haemophilus Test Medium (Agar) in A) 100 mm REF R01503, and B) 150 mm plates REF R04033,. Reason: Test organisms exhibit poor growth when grown using the test agar. The poor growth can give users incorrect AST zones when performing susceptibility tests..

Recalling firm
Remel Inc
Classification
Class II
Status
Terminated
Initiated
2017-02-09
Terminated
2019-05-01
Firm location
Lenexa, KS, United States

Product description

Remel, Haemophilus Test Medium (Agar) in A) 100 mm REF R01503, and B) 150 mm plates REF R04033,

Reason for recall

Test organisms exhibit poor growth when grown using the test agar. The poor growth can give users incorrect AST zones when performing susceptibility tests.

Data sourced from openFDA. This site is unofficial and independent of the FDA.